Generation of a novel model of bioengineered human oral mucosa with increased vascularization potential
Open Access
- 12 September 2021
- journal article
- research article
- Published by Wiley in Journal of Periodontal Research
- Vol. 56 (6) , 1116-1131
Abstract
Objective: The aim of this study was to generate novel models of bioartificial human oral mucosa with increased vascularization potential for future use as an advanced therapies medicinal product, by using different vascular and mesenchymal stem cell sources.Background: Oral mucosa substitutes could contribute to the clinical treatment of complex diseases affecting the oral cavity. Although several models of artificial oral mucosa have been described, biointegration is a major issue that could be favored by the generation of novel substitutes with increased vascularization potential once grafted in vivo.Methods: Three types of mesenchymal stem cells (MSCs) were obtained from adipose tissue, bone marrow, and dental pulp, and their in vitro potential was evaluated by inducing differentiation to the endothelial lineage using conditioning media. Then, 3D models of human artificial oral mucosa were generated using biocompatible fibrin‐agarose biomaterials combined with human oral mucosa fibroblasts and each type of MSC before and after induction to the endothelial lineage, using human umbilical vein endothelial cells (HUVEC) as controls. The vascularization potential of each oral mucosa substitute was assessed in vitro and in vivo in nude mice.Results: In vitro induction of MSCs kept in culture was able to increase the expression of VEGF, CD31, and vWF endothelial markers, especially in bone marrow and dental pulp‐MSCs, and numerous proteins with a role in vasculogenesis become overexpressed. Then, in vivo grafting resulted in a significant increase in blood vessels formation at the interface area between the graft and the host tissues, with significantly positive expression of VEGF, CD31, vWF, and CD34 as compared to negative controls, especially when pre‐differentiated MSCs derived from bone marrow and dental pulp were used. In addition, a significantly higher number of cells committed to the endothelial lineage expressing the same endothelial markers were found within the bioartificial tissue.Conclusion: Our results suggest that the use of pre‐differentiated MSCs could contribute to a rapid generation of a vascular network that may favor in vivo biointegration of bioengineered human oral mucosa substitutes.Keywords
This publication has 56 references indexed in Scilit:
- Evaluation of the Cell Viability of Human Wharton's Jelly Stem Cells for Use in Cell TherapyTissue Engineering Part C: Methods, 2012
- Epithelial and Stromal Developmental Patterns in a Novel Substitute of the Human Skin Generated with Fibrin-Agarose BiomaterialsCells Tissues Organs, 2011
- Macrophages overexpressing VEGF, transdifferentiate into endothelial-like cells in vitro and in vivoBiotechnology Letters, 2011
- Three dimensional dental epithelial-mesenchymal constructs of predetermined size and shape for tooth regenerationBiomaterials, 2010
- Transdifferentiation potentiality of human Wharton's jelly stem cells towards vascular endothelial cellsJournal of Cellular Physiology, 2010
- In vitro and in vivo cytokeratin patterns of expression in bioengineered human periodontal mucosaJournal of Periodontal Research, 2009
- Use of Human Mesenchymal Cells to Improve Vascularization in a Mouse Model for Scaffold-Based Dermal RegenerationTissue Engineering Part A, 2009
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Vascular endothelial growth factor (VEGF) – a valuable serum tumour marker in patients with colorectal cancer?European Journal of Surgical Oncology, 2001
- Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluationEuropean Journal of Cancer, 1996